U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017374) titled 'Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy' on May 22.
Brief Summary: Cardiac arrest remains a large contributor to morbidity and mortality. Animal studies suggest an improvement in mortality and neurological function with hypothermia after cardiac arrest, a finding that could not be verified in large clinical trials such as Target Temperature Management after Out-of-hospital Cardiac arrest (TTM) trial. Multimodal neuroprognostication is an important tool for differentiating patients that will recover after cardiac arrest, and currently only one biomarker is in clinical use. The purpose of this st...